دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Resmetirom for NASH: balancing promise and prudence
doi : 10.1016/S2468-1253(24)00049-9
Volume 9, Issue 4, April 2024, Page 273
Robust data on stenting for patients with chronic mesenteric ischaemia
Bernardo C Mendes, *Randall R DeMartino
doi : 10.1016/S2468-1253(23)00456-9
Volume 9, Issue 4, April 2024, Pages 274-275
The COSMIC-312 study: will it shape future combination therapies for advanced hepatocellular carcinoma?
Anna Saborowski, *Ana Lleo
doi : 10.1016/S2468-1253(24)00007-4
Volume 9, Issue 4, April 2024, Pages 275-276
A new tool for assessing hepatitis B treatment eligibility in Africa
*Serge Ouoba, Moussa Lingani
doi : 10.1016/S2468-1253(24)00006-2
Volume 9, Issue 4, April 2024, Pages 277-278
Haematopoietic stem-cell transplantation for patients with Crohn's disease: primum non nocere
*Rachele Ciccocioppo, Ludovit Gaspar
doi : 10.1016/S2468-1253(24)00004-9
Volume 9, Issue 4, April 2024, Pages 278-279
Eliminating viral hepatitis: no room for complacency
Rob Brierley
doi : 10.1016/S2468-1253(24)00042-6
Volume 9, Issue 4, April 2024, Pages 279-280
Harnessing the power of civil society to achieve hepatitis elimination
Danjuma Adda, Jessica Hicks, *Cary James, Alexandra Smith
doi : 10.1016/S2468-1253(23)00401-6
Volume 9, Issue 4, April 2024, Pages 281-282
Urgent need for lived experience in hepatitis B guideline development
Catherine Freeland, Wendy Lo, Kenneth Kabagambe, Su Wang, Danjuma Adda, Camilla S Graham, Robert Gish, Chari Cohen
doi : 10.1016/S2468-1253(23)00455-7
Volume 9, Issue 4, April 2024, Pages 282-284
Africa CDC's viral hepatitis prevention and control programme: a continental initiative to support elimination programmes
Hanna Amanuel Tesfahunei, *Mohammed Abdulaziz, Nafiisah Chotun, John W Ward, Mohamed Hassany, Jean Kaseya
doi : 10.1016/S2468-1253(23)00478-8
Volume 9, Issue 4, April 2024, Pages 284-286
WHO hepatitis C elimination targets: the global equity challenge
*Katherine Heath, Andrew Hill
doi : 10.1016/S2468-1253(23)00408-9
Volume 9, Issue 4, April 2024, Pages 286-288
Expression of concern—Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial
doi : 10.1016/S2468-1253(24)00039-6
Volume 9, Issue 4, April 2024, Page 288
The DESTIN trial: to step up or not?
Oscar Cahyadi, Vinay Dhir, John Leeds, Enrique de-Madaria, Nadeem Tehami
doi : 10.1016/S2468-1253(24)00008-6
Volume 9, Issue 4, April 2024, Page 289
The DESTIN trial: to step up or not?
Avinash Tiwari, Mayank Mehrotra, Ajmal Hasan, Jaya Agarwal, Gaurav Kumar Singh
doi : 10.1016/S2468-1253(24)00001-3
Volume 9, Issue 4, April 2024, Pages 289-290
The DESTIN trial: to step up or not? – Authors' reply
Ji Young Bang, *Shyam Varadarajulu
doi : 10.1016/S2468-1253(24)00016-5
Volume 9, Issue 4, April 2024, Pages 290-291
Comprehensive screening for superficial oesophageal squamous cell carcinoma and precancerous lesions
Daisuke Murakami, Masayuki Yamato, Takayoshi Nishino, Makoto Arai
doi : 10.1016/S2468-1253(24)00002-5
Volume 9, Issue 4, April 2024, Pages 291-292
Comprehensive screening for superficial oesophageal squamous cell carcinoma and precancerous lesions – Authors' reply
Xiang-Lei Yuan, *Bing Hu
doi : 10.1016/S2468-1253(24)00003-7
Volume 9, Issue 4, April 2024, Page 292
Gluten and non-coeliac gluten sensitivity: the nocebo effect and future avenues
Maurizio Mennini*, Federica Ferrari, Pasquale Parisi, Giovanni Di Nardo
doi : 10.1016/S2468-1253(23)00444-2
Volume 9, Issue 4, April 2024, Pages 292-293
Gluten and non-coeliac gluten sensitivity: the nocebo effect and future avenues – Authors' reply
Marlijne C G de Graaf, Daniel Keszthelyi, Fred J P H Brouns, Louise Dye, *Daisy M A E Jonkers, on behalf of all authors
doi : 10.1016/S2468-1253(24)00035-9
Volume 9, Issue 4, April 2024, Pages 293-294
Can genetically engineered pig livers offer patients precious time?
Bryant Furlow
doi : 10.1016/S2468-1253(24)00047-5
Volume 9, Issue 4, April 2024, Page 295
Research in Brief
Holly Baker
doi : 10.1016/S2468-1253(24)00050-5
Volume 9, Issue 4, April 2024, Page 296
You Are What You Eat: a Twin Experiment
Hollie Sherwood-Martin
doi : 10.1016/S2468-1253(24)00051-7
Volume 9, Issue 4, April 2024, Page 297
Covered versus bare-metal stenting of the mesenteric arteries in patients with chronic mesenteric ischaemia (CoBaGI): a multicentre, patient-blinded and investigator-blinded, randomised controlled trial
Luke G Terlouw*, Louisa J D van Dijk*, Desirée van Noord, Olaf J Bakker, Diederik C Bijdevaate, Nicole S Erler, Bram Fioole, Jihan Harki, Daniel A F van den Heuvel, Jan Willem Hinnen, Jeroen J Kolkman, Suzan Nikkessen, André S van Petersen, Henk F M Smits, Hence J M Verhagen, Annemarie C de Vries, Jean-Paul P M de Vries, Dammis Vroegindeweij, Robert H Geelkerken, Marco J Bruno*, Adriaan Moelker*, on behalf of the Dutch Mesenteric Ischemia Study Group
doi : 10.1016/S2468-1253(23)00402-8
Volume 9, Issue 4, April 2024, Pages 299-309
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
Thomas Yau, Ahmed Kaseb, Ann-Lii Cheng, Shukui Qin, Andrew X Zhu, Stephen L Chan, Tamar Melkadze, Wattana Sukeepaisarnjaroen, Valery Breder, Gontran Verset, Edward Gane, Ivan Borbath, Jose David Gomez Rangel, Baek-Yeol Ryoo, Tamta Makharadze, Philippe Merle, Fawzi Benzaghou, Steven Milwee, Zhong Wang, Dominic Curran, Robin Kate Kelley*, Lorenza Rimassa
doi : 10.1016/S2468-1253(23)00454-5
Volume 9, Issue 4, April 2024, Pages 310-322
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study
Nicolas Minier, Alice Nanelin Guingané, Edith Okeke, Edford Sinkala, Asgeir Johannessen, Monique I Andersson, Pantong Davwar, Hailemichael Desalegn, Mary Duguru, Fatou Fall, Souleyman Mboup, Tongai Maponga, Philippa C Matthews, Adrià Ram?rez Mena, Gibril Ndow, Stian M S Orlien, Nicholas Riches, Moussa Seydi, Mark Sonderup, C Wendy Spearman, Alexander J Stockdale, Jantjie Taljaard, Michael Vinikoor, Gilles Wandeler, Maud Lemoine*, Yusuke Shimakawa*, Roger Sombié
doi : 10.1016/S2468-1253(23)00449-1
Volume 9, Issue 4, April 2024, Pages 323-332
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial
James O Lindsay, Daniel Hind, Lizzie Swaby, Hannah Berntsson, Mike Bradburn, Uday Bannur C, Jennifer Byrne, Christopher Clarke, Lauren Desoysa, Ben Dickins, Shahida Din, Richard Emsley, Gemma A Foulds, John Gribben, Christopher Hawkey, Peter M Irving, Majid Kazmi, Ellen Lee, Amanda Loban, Alan Lobo, Yashwant Mahida, Gordon W Moran, Diana Papaioannou, Miles Parkes, Andrew Peniket, A Graham Pockley, Jack Satsangi, Sreedhar Subramanian, Simon Travis, Emily Turton, Ben Uttenthal, Sergio Rutella, John A Snowden
doi : 10.1016/S2468-1253(23)00460-0
Volume 9, Issue 4, April 2024, Pages 333-345
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
Graham S Cooke, Barnaby Flower, Evan Cunningham, Alison D Marshall, Jeffrey V Lazarus, Adam Palayew, Jidong Jia, Rakesh Aggarwal, Mamum Al-Mahtab, Yashuito Tanaka, Sook-Hyang Jeong, Kittiyod Poovorawan, Imam Waked, Lindsey Hiebert, Pham M Khue, Jason Grebely, Diana Alcantara-Payawal, Juan F Sanchez-Avila, Charles Mbendi, David H Muljono, Olufunmilayo Lesi, Hailemichael Desalegn, Saeed Hamid, Alexandre de Araujo, Hugo Cheinquer, Charles A Onyekwere, Ruslan Malyuta, Iryna Ivanchuk, David L Thomas, Nikolay Pimenov, Vladimir Chulanov, Mae Ashworth Dirac, Hannah Han, John W Ward
doi : 10.1016/S2468-1253(23)00321-7
Volume 9, Issue 4, April 2024, Pages 346-365
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
Alison D Marshall, Alex R Willing, Abe Kairouz, Evan B Cunningham, Alice Wheeler, Nicholas O’Brien, Vidura Perera, John W Ward, Lindsey Hiebert, Louisa Degenhardt, Behzad Hajarizadeh, Samantha Colledge, Matthew Hickman, Danielle Jawad, Jeffrey V Lazarus, Gail V Matthews, Andrew Scheibe, Peter Vickerman, Gregory J Dore, Jason Grebely on behalf of the Global HCV and HIV Treatment Restrictions Group
doi : 10.1016/S2468-1253(23)00335-7
Volume 9, Issue 4, April 2024, Pages 366-382
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection
Marion Delphin, Khadija Said Mohammed, Louise O Downs, Sheila F Lumley, Elizabeth Waddilove, Dorcas Okanda, Nadia Aliyan, Marije Van Schalkwyk, Motswedi Anderson, Ponsiano Ocama, Tongai Maponga, Judith Torimiro, Collins Iwuji, Thumbi Ndung’u, Philippa C Matthews*, Jantjie Taljaard
doi : 10.1016/S2468-1253(23)00315-1
Volume 9, Issue 4, April 2024, Pages 383-392
